You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康拓醫療(688314.SH)業績快報:2021年度淨利升55.83%至8162.65萬元
格隆匯 02-24 16:12

格隆匯2月24日丨康拓醫療(688314.SH)披露2021年度業績快報,報吿期內,公司實現營業收入2.13億元,同比增長29.54%;歸屬於母公司所有者淨利潤8162.65萬元,同比增長55.83%;歸屬於母公司所有者的扣除非經常性損益的淨利潤6640.14萬元,同比增長46.34%。

2021年,公司持續加強產品市場推廣的拓展力度及覆蓋範圍,加強銷售渠道的拓展。公司各類主要產品收入均保持增長態勢,PEEK材料神經外科產品滲透率持續提升,報吿期內該產品實現銷售收入1.24億元,同比增長44.69%,銷售收入佔主營業務收入的佔比提升至59.93%,同比提升了5.96個百分點;公司其他產品實現銷售收入8266.03萬元,同比增長13.42%。同時,公司歸屬於母公司所有者淨利潤的增長也受益於報吿期內公司積極將閒置的資金進行保本型理財產生的投資收益增加及收到的各類政府補助。

2021年度,公司財務狀況良好。報吿期末總資產5.73億元,較報吿期初增長96.70%;歸屬於母公司的所有者權益5.03億元,較報吿期初增長105.83%;歸屬於母公司所有者的每股淨資產為8.67元/股,較報吿期初增長54.27%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account